| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |